Business NewsPR NewsWire • Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International

Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International

Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International

PHILADELPHIA and LONDON, June 26, 2011 /PRNewswire/ -- The pharmaceutical industry spent less on drug R&D last year than at any time in the last three years, according to data released today from the 2011 Pharmaceutical R&D Factbook complied by CMR International, a Thomson Reuters business.

View More : http://www.prnewswire.com/news-releases/drug-dropout-in-clinical-trials-is-at-unsustainable-levels-according-to-thomson-...
Releted News by prnewswire
New! GameUpTop Offerings from Leading Educational Games Publishers, Live on BrainPOP
CEO Matt Barrie Wins Ernst & Young Technology Entrepreneur of the Year - Eastern Region
Economy Negatively Impacted Employee Benefits More in 2011
Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR International
Announcing The RealReal: The First Designer Resale Flash Sale Site Launches
Albion bag the Bodog Bootie